logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
P

Pharmaceutical Statistics

IF1.4
Papers40
Citations
Journal Papers 40
Publication Date
delete
Evaluating Safety Rules in Ongoing Dose-Escalation Trials Using BOIN: A Comparative Analysis of Criteria and Their Impact on Dose-Level Safety Assessments
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteEnglert, Stefan; Prior, Thomas J.; Mitra, Anirban; Sanusi, Busola; Zhang, Liangcai; Di Scala, Lilla
deleteShare
deleteSave
Using Off-Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteRehal, Sunita; Best, Nicky; Watts, Sarah; Drury, Thomas
deleteShare
deleteSave
Bayesian Power-Based Sample Size Determination for Single-Arm Clinical Trials With Time-to-Event Endpoints
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHoriguchi, Go; Yokota, Isao; Teramukai, Satoshi
deleteShare
deleteSave
Within-Trial Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHojbjerre-Frandsen, Emilie; Schuler, Alejandro
deleteShare
deleteSave
Penalized Variable Selection for Joint AFT Random-Effect Model With Clustered Competing-Risks Data
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHao, Lin; Do Ha, Il
deleteShare
deleteSave
Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteJia, Sihan; Wang, Shirui; Qin, Gengsheng
deleteShare
deleteSave
An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteSenevirathne, Hasika K. Wickrama; Dutta, Sandipan
deleteShare
deleteSave
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance Bias
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteWolfsegger, Martin J.; Xu, Peixin; Cotterill, Amy; Schutz, Helmut; Jaki, Thomas F.
deleteShare
deleteSave
New, Shorter Small-Sample Intervals for Vaccine Efficacy
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteGasparini, Mauro; Di Trani, Vincenzo; Ratta, Marco
deleteShare
deleteSave
Assessment of Responder Analyses for Patient-Reported Outcomes With Varying Variability Between Intervention Groups: Maximum Responder Threshold and Effect
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteCappelleri, Joseph C.; Ma, Jia; Di Fusco, Manuela; Sun, Xiaowu
deleteShare
deleteSave
Handling Missing Data in Participants with Baseline but No Post-Baseline Data
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteMallinckrodt, Craig; Lipkovich, Ilya; Dickson, Samuel; Hendrix, Suzanne; Molenberghs, Geert
deleteShare
deleteSave
A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteLiu, Xiaofei; Thomas, Nele Henrike; Asikanius, Elina; Pothet, Caroline; Grosshennig, Anika; Koch, Armin
deleteShare
deleteSave
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure Proportion
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteWang, Zhanfeng; Shen, Zerui; Ming, Ruixing; Tu, Dongsheng
deleteShare
deleteSave
Application of Causal Inference to Establish Assay Effect in the Absence of a Bridging Study: A Case Study of MenACWY-CRM Conjugate Vaccine Data
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteAdani, Meike; Noirjean, Silvia; Callegaro, Andrea; Keshavan, Pavitra; Costantini, Marco
deleteShare
deleteSave
Multiplicity Adjustment Methods for a Three-Way Crossover Bioequivalence Study
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteHinds, David; Grosser, Stella; Sun, Wanjie
deleteShare
deleteSave
Leveraging Two-Stage δ Global Sensibility Analysis Method to Inform Parameter Estimation in PBPK Models
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteCuquerella-Gilabert, Marina; De Carlo, Alessandro; Sanchez Herrero, Sergio; Reig-Lopez, Javier; Merino-Sanjuan, Matilde; Tosca, Elena M.; Mangas-Sanjuan, Victor; Magni, Paolo
deleteShare
deleteSave
Unblinded by the Night: Predictive Power for Complex Bayesian Adaptive Trials When Sight Privileges Vary
deletePharmaceutical Statistics
IF1.4
delete2026-03-01
delete0
PREAI
deleteGajewski, Byron J.; Beall, Jonathan; Nimkar, Kaustubh; Martin, Renee' H.
deleteShare
deleteSave
Robust Modestly Weighted Log-Rank Tests
deletePharmaceutical Statistics
IF1.4
delete2026-01-01
delete0
PREAI
deleteMagirr, Dominic; Ohrn, Fredrik
deleteShare
deleteSave
Selection of Quantitative Decision-Making Criteria Using Weighted Decision Error Rates
deletePharmaceutical Statistics
IF1.4
delete2026-01-01
delete0
PREAI
deleteBratton, Daniel J.
deleteShare
deleteSave
Confidence Intervals for Validation of Analytical Procedures Under ICH Q2(R2)
deletePharmaceutical Statistics
IF1.4
delete2026-01-01
delete0
PREAI
deleteFaya, Paul; Wolfe, Chad N.; Rauk, Adam P.
deleteShare
deleteSave